Oestrogen producing enzymes and mammary carcinogenesis: a review Ashok SubramanianMohamed SalhabKefah Mokbel Review 13 October 2007 Pages: 191 - 202
Taxane vs. taxane: is the duel at an end? A commentary on a phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study Sofyan M. RadaidehGeorge W. Sledge Invited Commentary 08 November 2007 Pages: 203 - 208
Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2 Ferdinando MannelloWenyi QinEdward R. Sauter Preclinical Study 12 October 2007 Pages: 209 - 218
Seasonal modulation of post-resection breast cancer metastasis Eun-Young OhPatricia A. WoodWilliam J. M. Hrushesky Preclinical Study 14 October 2007 Pages: 219 - 228
Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor Matthias KotzschAnieta M. SieuwertsJohn A. Foekens Preclinical Study 20 October 2007 Pages: 229 - 240
Additive effects of a prolactin receptor antagonist, G129R, and herceptin on inhibition of HER2-overexpressing breast cancer cells Michele L. ScottiJohn F. LangenheimWen Y. Chen Preclinical Study 23 October 2007 Pages: 241 - 250
2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique Paul A. FosterYaik T. HoAtul Purohit Preclinical Study 24 October 2007 Pages: 251 - 260
Adjuvant chemotherapy for breast cancer: a cost-utility analysis of FEC-D vs. FEC 100 Tallal YounisDaniel RaysonChris Skedgel Epidemiology 05 October 2007 Pages: 261 - 267
Vitamin supplement use and risk for breast cancer: the Shanghai Breast Cancer Study Tsogzolmaa DorjgochooMartha J. ShrubsoleWei Zheng Epidemiology 05 October 2007 Pages: 269 - 278
Polymorphisms in three base excision repair genes and breast cancer risk in Thai women Suleeporn SangrajrangPeter SchmezerOdilia Popanda Epidemiology 06 October 2007 Pages: 279 - 288
Benign breast disease heterogeneity: association with histopathology, age, and ethnicity Jingfang ChengShijing QiuMaria J. Worsham Epidemiology 05 October 2007 Pages: 289 - 296
On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk Isabelle SoerjomataramEero PukkalaJan Willem W. Coebergh Epidemiology Open access 12 October 2007 Pages: 297 - 302
Distant disease-free interval, site of first relapse and post-relapse survival in BRCA1- and BRCA2-associated compared to sporadic breast cancer patients Mieke KriegeCaroline SeynaeveJan G. M. Klijn Epidemiology 19 October 2007 Pages: 303 - 311
Paget’s disease of the nipple in a population based cohort Kristina DalbergHenrik HellborgFredrik Wärnberg Epidemiology 19 October 2007 Pages: 313 - 319
EGF promoter SNPs, plasma EGF levels and risk of breast cancer in Chinese women Yan WangTian TianHongbing Shen Epidemiology 17 October 2007 Pages: 321 - 327
Is obesity an independent prognosis factor in woman breast cancer? Bilal MajedThierry MoreauBernard Asselain Epidemiology 16 October 2007 Pages: 329 - 342
Development of a high sensitivity, nested Q-PCR assay for mouse and human aromatase Giujian LiuYu-sheen WuRichard J. Santen Epidemiology 02 November 2007 Pages: 343 - 351
Development of a high sensitivity, nested Q-PCR assay for mouse and human aromatase Gui-Jian LiuYu-sheen WuRichard J. Santen Erratum 04 December 2007 Pages: 353 - 353
The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method Katherine H. Rak TkaczukOlga GoloubevaPaul O. P. Ts’o Clinical Trial 07 December 2007 Pages: 355 - 364
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors N. Lynn HenryJon T. GilesDaniel J. Clauw Clinical Trial 06 October 2007 Pages: 365 - 372
Does computer-aided detection (CAD) contribute to the performance of digital mammography in a self-referred population? Beniamino BrancatoNehmat HoussamiStefano Ciatto Clinical Trial 16 October 2007 Pages: 373 - 376
Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer T. A. TrainaI. PoggesiM. N. Dickler Clinical Trial 20 October 2007 Pages: 377 - 388
Invasiveness gene signature predicts a favorable outcome also in estrogen receptor-positive primary breast cancers treated with adjuvant tamoxifen Danila CoradiniManuela GariboldiMaria Grazia Daidone Letter to the Editor 04 October 2007 Pages: 389 - 390
